Atlas Trials

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2

Clinical trial NCT03782259 · COMPLETED

Trial details

NCT number
NCT03782259
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusMyocardial FibrosisMyocardial Inflammation
Start date
2019-02-26
Primary completion
2022-11-16
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.